Integra LifeSciences to Present at Healthcare Conferences in June 2018
24 May 2018 - 6:01AM
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading
global medical technology company, will present at the following
healthcare conferences in June:
- On Wednesday, June 6, 2018 at 3:30 p.m. ET, Peter Arduini,
president and chief executive officer, will present at the
Jefferies 2018 Healthcare Conference in New York, NY. The session
will be available through live audio webcast and can be accessed
from the Investor section of www.integralife.com.
- On Wednesday, June 20, 2018 at 8:30 a.m. ET, Robert T. Davis,
Jr., president – orthopedics & tissue technologies, will
present at the JMP Securities Life Sciences Conference in New York,
NY.
About Integra LifeSciencesIntegra LifeSciences
is a global leader in regenerative technologies, neurosurgical and
extremity orthopedic solutions dedicated to limiting uncertainty
for clinicians, so they can focus on providing the best patient
care. Integra offers a comprehensive portfolio of high quality,
leadership brands that include AmnioExcel®, Bactiseal®, Cadence®,
Certas™, Codman®, CUSA®, DuraGen®, DuraSeal®, ICP Express®,
Integra®, MediHoney®, MicroFrance®, PriMatrix®, Salto Talaris®,
SurgiMend®, TCC-EZ®, Titan™ and VersaTru™. For the latest
news and information about Integra and its brands, please visit
www.integralife.com.
Statements made at the upcoming conferences may
be forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Such forward-looking
statements involve risks and uncertainties that could cause actual
results to differ from predicted results. Forward-looking factors
that may be discussed include, but are not limited to, future
financial performance, new product development, governmental
approvals, market potential and resulting sales as well as
potential therapeutic applications, and additional acquisitions.
These risks and uncertainties include market conditions and other
factors beyond the Company's control and the economic, competitive,
governmental, technological and other factors identified under the
heading "Risk Factors" included in item 1A of Integra's Annual
Report on Form 10-K for the year ended December 31, 2017 and
information contained in subsequent filings with the Securities and
Exchange Commission could affect actual results. These
forward-looking statements are made only as the date thereof, and
the Company undertakes no obligation to update or revise the
forward-looking statements, whether as a result of new information,
future events or otherwise.
|
|
Investor
Relations Contacts: |
|
Sravan Emany |
|
Vice President,
Treasury & Investor Relations |
|
(609) 936-2488 |
|
sravan.emany@integralife.com |
|
|
|
Michael Beaulieu |
|
Director, Investor
Relations |
|
(609) 750-2827 |
|
michael.beaulieu@integralife.com |
|
|
Media
Contact: |
|
Laurene Isip |
|
Senior Director, Global
Corporate Communications |
|
(609) 750-7984 |
|
laurene.isip@integralife.com |
|
|
|
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From Apr 2024 to May 2024
Integra LifeSciences (NASDAQ:IART)
Historical Stock Chart
From May 2023 to May 2024